ANDA 206716, held by Ingenus Pharms LLC. Mafenide Acetate.
As of Nov 16, 2026, ANDA 206716 (Mafenide Acetate), held by Ingenus Pharms LLC, was first approved by FDA on Jul 31, 2017, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 31, 2017 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Mafenide Acetate5% ยท for solution;topical | Mafenide Acetate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters